Join BioEye in our ground-breaking clinical studies
Drive advances in identifying and managing concussion, detection of drug use and neurodegenerative disease, as well as other areas where accurate measurement of eye biomarkers can improve care.
Join our scientific trials
BioEye welcomes sporting partners
We proudly invite interested sporting codes to join the AFL to participate in BioEye concussion studies, backed by independent researchers from Monash University’s Neuroscience Department.
BioEye welcomes clinical partners
We welcome proposals from clinical centres regarding future research using the BioEye technology platform.
“Changes to the way the eyes track a target and respond to light, can be used to help identify the earliest stages of concussion and track its recovery. BioEye has the potential to provide a quick, easy to use, sideline measure of suspected concussion that is available to collision sport athletes of all ages at all levels.”
A/Prof Joanne Fielding
Monash University Department of Neuroscience
Why sports should partner with BioEye in concussion trials
Concussion is a significant concern. Player health, along with media and community groundswell of attention to the issue has prompted action by sporting codes to do more to protect participants.
Underdiagnosis is a major issue. The Journal of Sports Medicine reports around 50% of concussions go unreported or undiagnosed.
The BioEye solution. BioEye is an accurate and inexpensive mobile technology that’s easy to use.
Collaborate in industry-leading clinical studies
Utilise the latest technology
Partner with top Australian medical research centre
Prioritise the health and safety of your players
“The health and safety of our players is of paramount concern to the AFL and we are committed to further research in this area. We are encouraging all clubs to be involved in these studies.”
AFL General Counsel
In 2021 BioEye entered into a partnership with the Australian Football League (AFL) and Monash University Neuroscience Department for an independent clinical study of BioEye’s utility in the diagnosis and management of concussion.
This trial is evaluating the sensitivity of the BioEye system to diagnose concussion as well as its ability to track the recovery of concussed athletes.
“Preliminary studies demonstrate that BioEye sensitively records abnormal function in any, or all of, smooth pursuit, gaze holding, convergence and pupillary constriction after concussive head injury.”
Prof Owen B White
MB.BS, MSc, MD, PhD, FNANOS, FRACP
Co-director of Monash University Neuroscience Laboratory
What is involved in a concussion research trial?
BioEye and Monash University are committed to ensuring our trial logistics are tailored around the needs of our sporting partners, with limited disruption to your day-to-day activities.
- Tailored around your needs
- Limited disruption to usual activities
- No cost for participation
- Access to academically rigorous insights
- Trial results to be available within 12 months
How clinical partners can benefit from a BioEye partnership
We welcome proposals regarding future research using the BioEye technology platform.
Proven research mindset Our productive partnership with Monash University Neuroscience Department has demonstrated our commitment to rigorous, independent research with world-leading centres.
So many important problems to solve. There is a huge scope of research areas BioEye is interested to explore beyond the diagnosis and monitoring of concussion. Accurate measurement of eye biomarkers can apply to a multitude of clinical settings, where gaining insight into cognitive function is valuable.